Dr. MacVicar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
8940 N Wood Sage Rd
Peoria, IL 61615Phone+1 309-243-3000Fax+1 309-243-3215- Is this information wrong?
Education & Training
University of Michigan Health SystemFellowship, Hematology and Medical Oncology, 2002 - 2005- University of Michigan Health SystemResidency, Internal Medicine, 1999 - 2002
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1999
Certifications & Licensure
IL State Medical License 2005 - 2026
MI State Medical License 1999 - 2015- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2013
Clinical Trials
- Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer Start of enrollment: 2006 Sep 26
- First-line Everolimus +/- Paclitaxel for Cisplatin-ineligible Patients With Advanced Urothelial Carcinoma Start of enrollment: 2010 Dec 01
- Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2 Start of enrollment: 2023 Sep 22
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 1 citationsLong-term Outcomes from a Phase 2 Study of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer (SWOG S1314; NCT02177695).Thomas W Flaig, Catherine M Tangen, Siamak Daneshmand, Ajjai Shivaram Alva, M Scott Lucia, David James McConkey, Dan Theodorescu, Amir Goldkorn, Matthew I Milowsky, Ri...> ;European Urology. 2023 Sep 1
- Results From a Randomized Phase II Trial of Sunitinib and Gemcitabine or Sunitinib in Advanced Renal Cell Carcinoma with Sarcomatoid Features: ECOG-ACRIN E1808.Bradley C Carthon, Se Eun Kim, David F McDermott, Janice P Dutcher, Maneka Puligandla, Judith Manola, Michael Pins, Michael A Carducci, Elizabeth R Plimack, Leonard J ...> ;Clinical Genitourinary Cancer. 2023 Oct 1
- Phase II Clinical and Translational Study of Everolimus ± Paclitaxel as First-Line Therapy in Cisplatin-Ineligible Advanced Urothelial Carcinoma.Tomi Jun, Noah M Hahn, Guru Sonpavde, Constantine Albany, Gary R MacVicar, Ralph Hauke, Mark Fleming, Theodore Gourdin, Bagi Jana, William K Oh, Patricia Taik, Huan Wa...> ;The Oncologist. 2022 Jun 8
- Join now to see all
Other
- Treatment of metastatic urothelial cancer of the bladder and urinary tractMacVicar GR, Bellmunt J, Hussain M
http://www.uptodate.com/contents/treatment-of-metastatic-urothelial-cancer-of-the-bladder-and-urinar
UpToDate, Wolters Kluwer Health - 2012-07-02
Press Mentions
Western Illinois Trial Site Organization First to Enroll Patient in Global Clinical Trial Investigating New Drugs Targeting Advanced Kidney CancerJune 23rd, 2021
Professional Memberships
- Member
Hospital Affiliations
Carle Health Methodist HospitalPeoria, Illinois
Veterans Affairs Illiana Health Care SystemDanville, Illinois
Edward Hines, Jr. Veterans Affairs HospitalHines, Illinois
OSF Saint Elizabeth Medical CenterOttawa, Illinois
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
